A localized salt-dependent aquagenic urticaria successfully treated with omalizumab.
Clin Exp Dermatol
; 47(12): 2339-2341, 2022 Dec.
Article
em En
| MEDLINE
| ID: mdl-36131614
We present the first case of a localized salt-dependent aquagenic urticaria confirmed by a challenge test. A good therapeutic response was achieved after only the first dose of omalizumab.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Urticária
/
Antialérgicos
Tipo de estudo:
Etiology_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article